Humer Kristian 4
4 · Viridian Therapeutics, Inc.\DE · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Humer Kristian
CFO and CBO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-02+90,000→ 90,000 totalExercise: $18.51Exp: 2032-02-02→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments through February 2, 2026, subject to the Reporting Person's continued service to Issuer through each vesting date.